0001209191-16-148159.txt : 20161103
0001209191-16-148159.hdr.sgml : 20161103
20161103161222
ACCESSION NUMBER: 0001209191-16-148159
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161103
FILED AS OF DATE: 20161103
DATE AS OF CHANGE: 20161103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC
CENTRAL INDEX KEY: 0001123494
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043306140
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL RD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: 5088938999
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duchemin Jeffrey
CENTRAL INDEX KEY: 0001585223
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33957
FILM NUMBER: 161971719
MAIL ADDRESS:
STREET 1: 14 EASTLAND TERRACE
CITY: HAVERHILL
STATE: MA
ZIP: 01830
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-11-03
0
0001123494
HARVARD BIOSCIENCE INC
HBIO
0001585223
Duchemin Jeffrey
HARVARD BIOSCIENCE, INC.
84 OCTOBER HILL ROAD
HOLLISTON
MA
01746
1
1
0
0
Chief Executive Officer
Common Stock
2016-11-03
4
P
0
15000
2.42
A
462623
D
This transaction was executed in several trades between $2.35 and $2.50. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes (a) a deferred stock award of 291,667 restricted stock units which shall vest in four equal installments on January 1, 2017, 2018, 2019 and 2020; (b) a deferred stock award of 51,675 restricted stock units which shall vest in three equal installments on January 1, 2017, 2018 and 2019; (c) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (c) 47,533 shares of common stock held by the Reporting Person.
This form has been signed under power of attorney.
/s/ Chad Porter, by power of attorney
2016-11-03